News
Pfizer’s Litfulo becomes first NHS drug for alopecia areata
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition t
